Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular calcium in calcified coronary stenosis
- Molecular classification
- Other (process/feature; not a gene/protein/family)
01
Overview
Vascular calcium in calcified coronary stenosis describes the accumulation of calcium salts (primarily hydroxyapatite) within the vessel wall, especially in the intima and media of coronary arteries with atherosclerotic plaques. This process mimics osteogenic differentiation of vascular smooth muscle cells and progresses from microcalcifications (unstable plaques) to extensive sheets or nodules (stable plaques or, rarely, eruptive, unstable nodules). Pathological calcification reduces vessel elasticity, impairs blood flow, and makes interventional procedures technically challenging. Although not a drug target per se, it is an important marker for cardiovascular risk and a focus of procedural strategies in interventional cardiology.
- Other names
- Coronary artery calcificationVascular calcification in coronary artery diseaseCoronary calciumCoronary calcified stenosis
02
Mechanism of action
Reduction of plaque burden (statins) Inhibition of bone-like mineralization pathways (bisphosphonates, experimental) Chelation or dissolution of calcium salts (experimental agents)
03
Biological functions
Pathological mineralizationPlaque stabilization and instabilityReduction in vascular elasticityAlteration of blood flow and perfusion
04
Disease associations
Cardiovascular diseaseCoronary artery diseaseAtherosclerosisPeripheral vascular diseaseRenal disease (context of medial calcification)
05
Safety considerations
High risk of stent failure, poor stent expansion, procedural complications during PCIIncreased risk for acute coronary syndromes and chronic ischemiaProgression contributes to arterial stiffness and impaired perfusion
06
Interacting drugs
Statins (indirect effect on calcified plaques)
4 more in the full profile.
07
Biomarkers
Coronary artery calcium score (Agatston score)CT angiography quantification of plaque calciumBlood levels of mineralization regulators (e.g., matrix Gla protein, fetuin-A—research context)
Beyond the preview
Go deeper on Vascular calcium in calcified coronary stenosis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vascular calcium in calcified coronary stenosis.